- NIH/Walter Reed
- United States of America
Dr. Piraye Yurttas Beim founded Celmatix in 2009 to empower women to be more proactive and informed about their fertility through better data, including genomics. She was on the front lines of the personalized medicine revolution during her doctoral work at MSKCC/Weill Cornell (NYC) and was inspired to create the company after completing her postdoctoral embryology research training at the University of Cambridge (UK). Realizing how many of the successful and career-minded women in her network were making major, life-defining decisions around fertility based on age alone, she set out to bring personalized medicine to reproductive health. In addition to her scientific credentials, Dr. Beim has also been widely recognized as an emerging business leader. She is a Fellow of the second class of the Aspen Institute Health Innovators Fellowship program, a member of the Aspen Global Leadership Network, and was named a NYC Venture Fellow by the NYCEDC, to Crain’s 40 Under 40, Top 15 founders disrupting their industries by Fortune, and a Top Female Founder by TechCrunch. She lives in New York City with her husband and three children.